Reports on the congestion of the painkiller market in the United States. Decline of sales of the top nine analgesic brands; Launching of Procter & Gamble Co.'s Aleve drug; Aleve's prescription heritage; Aleve's dosage; Aleve's childproof cap; Procter & Gamble Co.'s Encaprin; Bristol-Myers Squibb Co.'s abandonment of Excedrin; Problems in marketing Sterling Winthrop Inc.'s Bayer aspirin.
Processing Request
No Comments.